戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 y ) was performed (diagnostic standard [ TAB temporal artery biopsy ]).
2 nts suspected of having GCA should undergo a temporal artery biopsy.
3  Vascular tissue was obtained at the time of temporal artery biopsy.
4 erpes zoster antigen was detected on several temporal artery biopsies.
5 l in predicting the likelihood of a positive temporal artery biopsy among patients with a clinical su
6 genesis of the disease but have not replaced temporal artery biopsy as the gold standard for securing
7                                   However, a temporal artery biopsy excluded GCA, showing segmental s
8                                              Temporal artery biopsy findings were negative in 42% of
9 ), and 28 patients had negative results of a temporal artery biopsy for GCA (group 2).
10 1 core studies, 39% of patients referred for temporal artery biopsy had positive results.
11                                      In GCA, temporal artery biopsy may not be required in patients w
12 iopsy-positive GCA underwent two consecutive temporal artery biopsies, one prior to therapy and one w
13 cent of the control samples were obtained by temporal artery biopsy performed within 1 year of the bi
14 rd to age, frequency of positive findings on temporal artery biopsy (placebo 87%, MTX 79%), or comorb
15                In 56.5% of patients with TAB temporal artery biopsy -positive results (35 of 62), MR
16                                              Temporal artery biopsy practices vary greatly among trea
17  by angiography and 74 control patients with temporal artery biopsy-proven GCA without large vessel i
18                                              Temporal artery biopsy remains the diagnostic procedure
19                                      In GCA, temporal artery biopsy remains the standard for definiti
20 owed a significant association of VZV DNA to temporal artery biopsy samples positive for GCA compared
21                        Controls had negative temporal artery biopsy specimens during the same 32-year
22                                              Temporal artery biopsy specimens from patients with GCA
23                 The inflammatory response in temporal artery biopsy specimens was characterized by se
24             In a randomized masked study, 64 temporal artery biopsy specimens were analyzed by PCR fo
25 stochemical, and ultrastructural analyses of temporal artery biopsy specimens.
26  88.7% and specificity was 75.0% for the TAB temporal artery biopsy subcohort (first observer).
27 giant cell arteritis -negative results ( TAB temporal artery biopsy subcohort and total study cohort,
28 ic standard TAB temporal artery biopsy ( TAB temporal artery biopsy subcohort).
29 ers, with good interobserver agreement ( TAB temporal artery biopsy subcohort, kappa = 0.718; total s
30            In 53.0% of patients (98 of 185), temporal artery biopsy ( TAB temporal artery biopsy ) wa
31  comparison with the diagnostic standard TAB temporal artery biopsy ( TAB temporal artery biopsy subc
32                                          The temporal artery biopsy (TAB) has long been the standard
33                                              Temporal artery biopsy (TAB) remains the gold standard f
34                    We prospectively examined temporal artery biopsy (TAB) tissue from 50 consecutive
35                                              Temporal artery biopsy (TAB), performed for the diagnosi
36 ella-zoster virus antigen) was detectable in temporal artery biopsies taken from individuals with gia
37 ts (98 of 185), temporal artery biopsy ( TAB temporal artery biopsy ) was performed (diagnostic stand
38 ted GCA was examined in peripheral blood and temporal artery biopsies with protein quantification ass

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。